Veterinary Product Developer/Licence Holder: 100% Shareholding or Licence for Sale

Hilco is inviting offers by 12:00 BST on Tuesday, 23 September 2025 for “Project Bark,” a company that has developed a version of tramadol tablets for use with dogs, to help manage pain. The company is a Marketing Authorisation Holder of Tramalgesic 50mg tablets, and the licence may be purchased via a sale of 100% of the shares, or a novation of the licence in isolation.

Further information.